Luciane Rodrigues Pedreira de Cerqueira1, Denise L M Monteiro2,3, Stella R Taquette2, Nádia C P Rodrigues2,4, Alexandre J B Trajano2,5, Flavio Monteiro de Souza2, Bianca De Melo Araújo2. 1. Universidade do Estado do Rio de Janeiro, Hospital Universitário Pedro Ernesto, Núcleo Perinatal, Rio de Janeiro, Rio de Janeiro, Brazil. 2. Universidade do Estado do Rio de Janeiro, Faculdade de Ciências Médicas, Rio de Janeiro, Rio de Janeiro, Brazil. 3. Centro Universitário Serra dos Órgãos, Teresópolis, Rio de Janeiro, Brazil. 4. Escola Nacional de Saúde Pública Sergio Arouca, Rio de Janeiro, Rio de Janeiro, Brazil. 5. Universidade do Grande Rio, Duque de Caxias, Rio de Janeiro, Brazil.
Abstract
INTRODUCTION: In 2013, the World Health Organization (WHO) reported that 1.9 million pregnant women were infected with syphilis worldwide, of which 66.5% had adverse fetal effects in cases of untreated syphilis. Congenital syphilis contributes significantly to infant mortality, accounting for 305,000 perinatal deaths worldwide annually. AIM: To estimate the prevalence of syphilis in parturients, the incidence of congenital syphilis and the vertical transmission rate. MATERIAL AND METHODS: a cross-sectional study with data collected from 2041 parturients who had undergone treatment between 2012 and 2014 in the maternity section of the Pedro Ernesto Hospital of the State University of Rio de Janeiro, in the metropolitan area of Rio de Janeiro. The inclusion criterion was positive VDRL and treponemal test in a hospital environment. RESULTS: the prevalence of syphilis in pregnant women was 4.1% in 2012, 3.1% in 2013 and 5% in 2014, with official reporting of 15.6%, 25.0% and 48.1%, respectively. The incidence of congenital syphilis (CS) was 22/1,000 in live births (LB) in 2012; 17/1,000 LB in 2013 and 44.8/1,000 LB in 2014. CS underreporting during the period was 6.7%. Vertical transmission occurred in 65.8% of infants from infected mothers. It was concluded that, in 34.6% of the CS cases, maternal VDRL titers were = 1/4. CONCLUSION: Results demonstrate the magnitude of the disease, fragility of the reporting system in the assessment of the actual prevalence, impact on perinatal outcomes, and they are a warning about the real situation of syphilis, which is still underestimated in the State.
INTRODUCTION: In 2013, the World Health Organization (WHO) reported that 1.9 million pregnant women were infected with syphilis worldwide, of which 66.5% had adverse fetal effects in cases of untreated syphilis. Congenital syphilis contributes significantly to infant mortality, accounting for 305,000 perinatal deaths worldwide annually. AIM: To estimate the prevalence of syphilis in parturients, the incidence of congenital syphilis and the vertical transmission rate. MATERIAL AND METHODS: a cross-sectional study with data collected from 2041 parturients who had undergone treatment between 2012 and 2014 in the maternity section of the Pedro Ernesto Hospital of the State University of Rio de Janeiro, in the metropolitan area of Rio de Janeiro. The inclusion criterion was positive VDRL and treponemal test in a hospital environment. RESULTS: the prevalence of syphilis in pregnant women was 4.1% in 2012, 3.1% in 2013 and 5% in 2014, with official reporting of 15.6%, 25.0% and 48.1%, respectively. The incidence of congenital syphilis (CS) was 22/1,000 in live births (LB) in 2012; 17/1,000 LB in 2013 and 44.8/1,000 LB in 2014. CS underreporting during the period was 6.7%. Vertical transmission occurred in 65.8% of infants from infected mothers. It was concluded that, in 34.6% of the CS cases, maternal VDRL titers were = 1/4. CONCLUSION: Results demonstrate the magnitude of the disease, fragility of the reporting system in the assessment of the actual prevalence, impact on perinatal outcomes, and they are a warning about the real situation of syphilis, which is still underestimated in the State.
Authors: Rosa Maria Soares Madeira Domingues; Valeria Saracen; Zulmira Maria de Araújo Hartz; Maria do Carmo Leal Journal: Rev Saude Publica Date: 2013-02 Impact factor: 2.106
Authors: Melanie M Taylor; Shahul Ebrahim; Nadine Abiola; Didine Kaba Kinkodi; Minlangu Mpingulu; Jean Pierre Kabuayi; Felly Ekofo; Daniel R Newman; Thomas A Peterman; Mary L Kamb; Kassim Sidibe Journal: Int J STD AIDS Date: 2014-01-22 Impact factor: 1.359
Authors: Margot Kuo; Deborah M Money; Maria Alvarez; Jane A Buxton; Mel Krajden; Richard T Lester; Gina Ogilvie; Mark Gilbert Journal: J Obstet Gynaecol Can Date: 2014-06
Authors: Maria Isabel do Nascimento; Alfredo de Almeida Cunha; Elisângela Victor Guimarães; Felipe Silva Alvarez; Sandra Regina Dos Santos Muri Oliveira; Eduardo Loyola Villas Bôas Journal: Rev Bras Ginecol Obstet Date: 2012-02
Authors: Maria Alix Leite Araújo; Silvio Carlos Rocha de Freitas; Heber José de Moura; Ana Paula Soares Gondim; Raimunda Magalhães da Silva Journal: BMC Public Health Date: 2013-03-07 Impact factor: 3.295
Authors: Paula F Blatyta; Shannon Kelly; Ester Sabino; Liliana Preiss; Franciane Mendes; Anna B Carneiro-Proietti; Daniela de Oliveira Werneck Rodrigues; Rosimere Mota; Paula Loureiro; Claudia Maximo; Miriam Park; Alfredo Mendrone-Jr; Thelma T Gonçalez; Cesar de Almeida Neto; Brian Custer Journal: Transfusion Date: 2019-12-05 Impact factor: 3.157
Authors: Elizabeth M McClure; Sarah Saleem; Shivaprasad S Goudar; Sangappa Dhaded; G Guruprasad; Yogesh Kumar; Shiyam Sunder Tikmani; Masood Kadir; Jamal Raza; Haleema Yasmin; Janet L Moore; Jean Kim; Carla Bann; Lindsay Parlberg; Anna Aceituno; Waldemar A Carlo; Robert M Silver; Laura Lamberti; Janna Patterson; Robert L Goldenberg Journal: Reprod Health Date: 2018-06-22 Impact factor: 3.223